White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
Show more
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group (0R0O) currently trades at $369.80, while our model-based Fair Value estimate is $265.80, 28.1% below the price, so the stock looks overvalued today.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($14.72 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF
$203.71
$394.90
$711.18
73
Residual Income
$96.99
$113.69
$148.60
73
Growth DCF
$201.69
$376.14
$654.28
72
All 26 models by family
DCF Models
FCF DCF
$203.71
$394.90
$711.18
73
Owner Earnings
$159.96
$318.55
$580.90
70
5Y Revenue Exit
$157.40
$302.46
$496.54
67
5Y EBITDA Exit
$185.93
$360.77
$577.38
70
5Y P/E Exit
$154.68
$296.89
$456.65
66
10Y Revenue Exit
$165.06
$305.79
$515.85
62
10Y EBITDA Exit
$189.65
$347.36
$581.45
63
10Y P/E Exit
$169.46
$301.82
$483.48
60
Earnings-Based
Graham-Dodd
$90.37
$407.26
$558.33
61
Lynch FV
$106.24
$151.77
$197.31
58
PEG = 1.0
$106.24
$151.77
$197.31
55
EPV
$97.27
$120.98
$141.43
71
Dividend Discount
Gordon GGM
$76.64
$152.71
$231.25
64
DDM Multi-Stage
$76.64
$131.98
$161.20
64
Multiples
P/E Multiple
$199.35
$265.80
$332.25
63
P/S Multiple
$169.45
$225.93
$282.42
58
P/B Multiple
$169.45
$225.93
$282.42
55
EV/EBIT
$229.36
$323.43
$417.50
65
EV/EBITDA
$197.83
$281.40
$364.97
67
EV/Revenue
$137.37
$218.90
$300.44
53
Asset-Based
NCAV (Graham)
$51.87
$69.51
$103.74
54
Growth DCF
Growth DCF
$201.69
$376.14
$654.28
72
Rev-Margin DCF
$157.40
$300.17
$483.05
68
Economic Profit
Residual Income
$96.99
$113.69
$148.60
73
ROIC Compounder
$97.27
$138.71
$193.85
68
Growth Earnings
Growth-Adj P/E
$167.92
$239.88
$311.85
65
Open the full fair value analysis →
Overall quality
59/100
Of which business quality 57
· Market factors (momentum, volatility) 56
Profitability
52
Margins and returns on capital today
Quality Growth
52
Are margins and returns improving?
Cashflow
52
Earnings quality: real cash, not paper profit
Fin. Strength
39
Balance sheet, leverage, solvency risk
Investment
76
Disciplined investing over empire-building
Low Volatility
72
Calm price path (market factor)
Momentum
49
Price trend over the last 3–12 months (market factor)
52W Momentum
51
Distance to the 52-week high (market factor)
Net Issuance
92
Share count: buybacks or dilution?
Open the full quality analysis →
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Pick a strategy and jump into the live analysis with that exact screen applied.
Is UnitedHealth Group (0R0O) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $265.80 versus a price of $369.80, about −28% upside (overvalued).
What is the fair value of 0R0O?
Our model-based fair value for UnitedHealth Group is $265.80 (as of Sep 24, 2026), built from audited fundamentals. The current price: $369.80.
What is the quality score of 0R0O?
UnitedHealth Group has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UnitedHealth Group (0R0O)?
Our model-based price target is the fair value of $265.80 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario $171.66, optimistic scenario $332.25. It is a calculation from audited fundamentals, not an analyst target.
What is the UnitedHealth Group stock forecast for 2026?
Our models put fair value at $265.80, about −28% upside versus a price of $369.80 (overvalued). Cautious scenario $171.66, optimistic scenario $332.25. The calculation is refreshed regularly with new filings.
What is the revenue of UnitedHealth Group (0R0O)?
UnitedHealth Group reported trailing-twelve-month revenue of about $450B (latest available figure, as of Sep 24, 2026).
Does UnitedHealth Group pay a dividend?
UnitedHealth Group currently shows a dividend yield of about 1.20% relative to its recent price (as of Sep 24, 2026).
What growth is priced into UnitedHealth Group (0R0O)?
For today's price to be fair in a discounted-cash-flow model, UnitedHealth Group would have to grow free cash flow by +12.1 % per year for five years (discount rate 9.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +11.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0R0O use?
Our models discount UnitedHealth Group at 9.3 %: a base by market capitalisation (unknown), damped by beta 0.63, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For UnitedHealth Group that is +12.1 % per year a year over ten years, using the same discount rate (9.3 %) and the same formula as our fair value.
How much growth has UnitedHealth Group (0R0O) delivered so far?
Over the past 4 years revenue at UnitedHealth Group grew +11.7 % a year. The price currently implies +12.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of UnitedHealth Group (0R0O)?
The free-cash-flow yield on the price is 4.80 %: that much free cash flow UnitedHealth Group produces per unit of market value. When it exceeds the discount rate of our models (9.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of UnitedHealth Group (0R0O)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UnitedHealth Group it is $265.80 per share (as of Sep 24, 2026), against a price of $369.80. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is UnitedHealth Group stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0R0O trades above its calculated fair value: price $369.80, fair value $265.80, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0R0O?
No. The price is what the market pays today ($369.80); the fair value is what the company's own numbers justify ($265.80). For UnitedHealth Group the two are $104.00 per share apart. That gap is exactly why we show both numbers side by side.
How much is UnitedHealth Group worth?
The market values UnitedHealth Group at about $335B (market capitalisation, as of Sep 24, 2026). Per share that is $369.80; our models calculate a fair value of $265.80 per share.
What do the bullish and bearish scenarios say about 0R0O?
Our models span a range for UnitedHealth Group: cautious scenario $171.66, base $265.80, optimistic $332.25 per share (as of Sep 24, 2026, price $369.80). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 0R0O from its 52-week high?
UnitedHealth Group trades at $369.80, about 15% below its 52-week high of $435.37 and 44% above the low of $256.44 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $265.80 is for.
Is UnitedHealth Group stock attractive at the current price?
The data as of Sep 24, 2026: price $369.80, calculated fair value $265.80 (−28%), Quality Score 59/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0R0O calculated?
We run UnitedHealth Group through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $265.80, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. UnitedHealth Group itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on
is it worth investing now.
What is the share price of UnitedHealth Group (0R0O)?
The closing price on Oct 2, 2026 was $369.80. Our model-based fair value is $265.80, about −28% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UnitedHealth Group right now?
The price sits above even our optimistic bull case ($332.25). The favourable scenario is already priced in. Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($171.66 to $332.25) leaves room in how you read the outcome.
Key figures of UnitedHealth Group
How large is the market capitalisation of UnitedHealth Group (0R0O)?
The market capitalisation of UnitedHealth Group is $335B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of UnitedHealth Group (0R0O)?
The price-to-earnings ratio of UnitedHealth Group is 0.2 (as of Jul 30, 2026). Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What are the earnings per share of UnitedHealth Group (0R0O)?
Earnings per share at UnitedHealth Group are $23.89 (price ÷ EPS = P/E 0.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of UnitedHealth Group (0R0O)?
The dividend yield of UnitedHealth Group is 1.2% (payout 18.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of UnitedHealth Group (0R0O)?
The net margin of UnitedHealth Group is 2.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UnitedHealth Group (0R0O)?
The return on equity (ROE) of UnitedHealth Group is 14.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UnitedHealth Group (0R0O)?
On an EBIT basis the return on assets of UnitedHealth Group is 10.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UnitedHealth Group (0R0O)?
The operating margin of UnitedHealth Group is 7.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UnitedHealth Group (0R0O)?
Revenue at UnitedHealth Group is growing +0.4% versus a year earlier (3y avg +11.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UnitedHealth Group (0R0O)?
Earnings per share at UnitedHealth Group are growing +61.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does UnitedHealth Group (0R0O) carry?
The net debt of UnitedHealth Group is $54.0B (fiscal year 2025, ≈ 3.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
